These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29633302)

  • 1. Evaluation of sex-by-formulation interaction in bioequivalence studies of efavirenz tablets.
    González-Rojano E; Abad-Santos F; Ochoa D; Román M; Marcotegui J; Álvarez C; Gordon J; García-Arieta A
    Br J Clin Pharmacol; 2018 Aug; 84(8):1729-1737. PubMed ID: 29633302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-by-formulation interaction assessed through a bioequivalence study of efavirenz tablets.
    Ibarra M; Magallanes L; Lorier M; Vázquez M; Fagiolino P
    Eur J Pharm Sci; 2016 Mar; 85():106-11. PubMed ID: 26850681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-by-formulation interaction in bioequivalence trials with transdermal patches.
    González-Rojano E; Marcotegui J; Morales-Alcelay S; Álvarez C; Gordon J; Abad-Santos F; García-Arieta A
    Eur J Clin Pharmacol; 2019 Jun; 75(6):801-808. PubMed ID: 30725220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-by-formulation interaction in bioequivalence studies: the importance of formulations and experimental conditions.
    Ibarra M; Vázquez M; Fagiolino P
    Br J Clin Pharmacol; 2019 Apr; 85(4):669-671. PubMed ID: 30536659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioavailability of a generic capsule formulation of the reverse transcriptase inhibitor efavirenz and the innovator product.
    Marier JF; Morin I; Al-Numani D; Stiles M; Morelli G; Tippabhotla SK; Vijan T; Singla AK; Garg M; Di Marco M; Monif T
    Int J Clin Pharmacol Ther; 2006 Apr; 44(4):180-4. PubMed ID: 16625987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
    Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro-in vivo correlation of efavirenz tablets using GastroPlus®.
    Honório Tda S; Pinto EC; Rocha HV; Esteves VS; dos Santos TC; Castro HC; Rodrigues CR; de Sousa VP; Cabral LM
    AAPS PharmSciTech; 2013 Sep; 14(3):1244-54. PubMed ID: 23943401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to 'Sex-by-formulation interaction in bioequivalence studies: the importance of formulations and experimental conditions' by Ibarra et al.
    González-Rojano E; Abad-Santos F; Gordon J; García-Arieta A
    Br J Clin Pharmacol; 2019 Apr; 85(4):857-858. PubMed ID: 30690756
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation on the Existence of Sex-By-Formulation Interaction in Bioequivalence Trials.
    González-Rojano E; Marcotegui J; Ochoa D; Román M; Álvarez C; Gordon J; Abad-Santos F; García-Arieta A
    Clin Pharmacol Ther; 2019 Nov; 106(5):1099-1112. PubMed ID: 31183851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability in healthy adults of efavirenz capsule contents mixed with a small amount of food.
    Kaul S; Ji P; Lu M; Nguyen KL; Shangguan T; Grasela D
    Am J Health Syst Pharm; 2010 Feb; 67(3):217-22. PubMed ID: 20101064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Effect on Average Bioequivalence.
    Ibarra M; Vázquez M; Fagiolino P
    Clin Ther; 2017 Jan; 39(1):23-33. PubMed ID: 28034518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence of methylphenidate immediate-release tablets using a replicated study design to characterize intrasubject variability.
    Meyer MC; Straughn AB; Jarvi EJ; Patrick KS; Pelsor FR; Williams RL; Patnaik R; Chen ML; Shah VP
    Pharm Res; 2000 Apr; 17(4):381-4. PubMed ID: 10870979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence evaluation of two strengths of risperidone tablet formulations in healthy volunteers.
    Cánovas M; Delgadillo J; Torres F; Riba N; Cebrecos J; Pelagio P; Cabré F
    Int J Clin Pharmacol Ther; 2009 Feb; 47(2):124-31. PubMed ID: 19203569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen.
    Mathias AA; Hinkle J; Menning M; Hui J; Kaul S; Kearney BP;
    J Acquir Immune Defic Syndr; 2007 Oct; 46(2):167-73. PubMed ID: 17667331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bioequivalence of highly variable drugs and drug products.
    Midha KK; Rawson MJ; Hubbard JW
    Int J Clin Pharmacol Ther; 2005 Oct; 43(10):485-98. PubMed ID: 16240706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetic and bioequivalence evaluation of two formulations of morniflumate 350-mg tablets in healthy male subjects
.
    Lee H; Yim SV; Kim BH; Lee S
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):95-101. PubMed ID: 27841153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and bioavailability studies of 5 mg mosapride tablets in healthy Korean volunteers.
    Kim SH; Park YS; Kim JM; Park HJ; Lee MH; Park HK; Kim YJ; Cho SH; Shaw LM; Kang JS
    Int J Clin Pharmacol Ther; 2012 Jul; 50(7):524-31. PubMed ID: 22541755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).
    Nakade S; Komaba J; Ohno T; Kitagawa J; Furukawa K; Miyata Y
    Int J Clin Pharmacol Ther; 2008 Jan; 46(1):42-7. PubMed ID: 18218297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
    Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
    Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation.
    Kakuda TN; Leopold L; Timmers M; Van De Casteele T; Hillewaert V; Tomaka FL; Hoetelmans RM
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):805-16. PubMed ID: 25109510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.